Kun Meng

930 total citations
19 papers, 494 citations indexed

About

Kun Meng is a scholar working on Pharmacology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Kun Meng has authored 19 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Pathology and Forensic Medicine and 6 papers in Cancer Research. Recurrent topics in Kun Meng's work include Medicinal Plant Pharmacodynamics Research (8 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Mechanisms and Therapy (4 papers). Kun Meng is often cited by papers focused on Medicinal Plant Pharmacodynamics Research (8 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Mechanisms and Therapy (4 papers). Kun Meng collaborates with scholars based in China, Canada and Hungary. Kun Meng's co-authors include Bin Ye, Limin Zheng, Dan Feng, Huijuan Wang, Yanhong Jia, Lixin Xie, Lian Li, Huimin Tao, Shu Li and Jun Jiang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Kun Meng

18 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kun Meng China 10 269 206 156 111 103 19 494
GI Murray United Kingdom 4 319 1.2× 110 0.5× 99 0.6× 74 0.7× 122 1.2× 5 497
Lang Li China 12 389 1.4× 79 0.4× 222 1.4× 62 0.6× 188 1.8× 21 720
Shun-Fa Yang Taiwan 14 348 1.3× 45 0.2× 180 1.2× 64 0.6× 112 1.1× 21 496
Jinbo Yang China 8 329 1.2× 50 0.2× 169 1.1× 234 2.1× 417 4.0× 13 734
Kiyomi Yamauchi Japan 9 118 0.4× 192 0.9× 62 0.4× 73 0.7× 104 1.0× 9 513
Jianting Wen China 11 246 0.9× 52 0.3× 200 1.3× 53 0.5× 33 0.3× 43 420
Mi Ni Huang China 7 249 0.9× 139 0.7× 305 2.0× 17 0.2× 150 1.5× 11 699
Mingen Lin China 8 202 0.8× 135 0.7× 58 0.4× 80 0.7× 178 1.7× 18 473

Countries citing papers authored by Kun Meng

Since Specialization
Citations

This map shows the geographic impact of Kun Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Meng more than expected).

Fields of papers citing papers by Kun Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Meng. The network helps show where Kun Meng may publish in the future.

Co-authorship network of co-authors of Kun Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Meng. A scholar is included among the top collaborators of Kun Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Meng. Kun Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Y. S., et al.. (2025). Unveiling the glymphatic system’s impact on neurodegenerative diseases: a comprehensive bibliometric analysis (2012–2024). Frontiers in Aging Neuroscience. 17. 1598608–1598608.
2.
Tang, Jian, Yu Chen, Ying Xia, et al.. (2024). The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics. SHILAP Revista de lepidopterología. 5(8). e663–e663. 9 indexed citations
3.
Tao, Huimin, Mingyu Liu, Yuan Wang, et al.. (2021). Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation. Frontiers in Immunology. 12. 609295–609295. 57 indexed citations
4.
5.
Qin, Shukui, Qing Li, Jian Xu, et al.. (2020). Icaritin‐induced immunomodulatory efficacy in advanced hepatitis B virus‐related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival. Cancer Science. 111(11). 4218–4231. 53 indexed citations
6.
7.
Zhang, Qi, Hai Zhu, Jian Xiong, et al.. (2019). Icaritin promotes tumor T‐cell infiltration and induces antitumor immunity in mice. European Journal of Immunology. 49(12). 2235–2244. 65 indexed citations
8.
Qin, Shukui, Qing Li, Jianmin Xu, et al.. (2019). Abstract CT148: Small molecule immune-modulator icaritin: Safety, durable survival and inflammation-immune biomarkers in advanced hepatocellular carcinoma. Cancer Research. 79(13_Supplement). CT148–CT148. 1 indexed citations
9.
You, Hui, Kun Meng, & Zhaoyi Wang. (2018). The ER-α36/EGFR signaling loop promotes growth of hepatocellular carcinoma cells. Steroids. 134. 78–87. 18 indexed citations
10.
Sun, Yan, Qing Li, Jianming Xu, et al.. (2018). A multicenter, single arm phase II trial of a small molecule immune-modulator icaritin: Safety, overall survival, immune dynamics, and PD-L1 expression in advanced hepatocellular carcinoma.. Journal of Clinical Oncology. 36(15_suppl). 4077–4077. 8 indexed citations
11.
Chen, Min, Ali G. Turhan, Hongxia Ding, et al.. (2017). Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex. Oncotarget. 8(27). 43662–43677. 17 indexed citations
12.
13.
Katona, Ëva, et al.. (2016). Neutralizing autoantibody against factor XIII A subunit resulted in severe bleeding diathesis with a fatal outcome – characterization of the antibody. Journal of Thrombosis and Haemostasis. 14(8). 1517–1520. 6 indexed citations
14.
Guo, Yuming, Jing Wang, Hai Zhu, et al.. (2016). A novel anticancer agent SNG1153 inhibits growth of lung cancer stem/progenitor cells. Oncotarget. 7(29). 45158–45170. 5 indexed citations
15.
Vézina, Catherine, Zsuzsanna Bereczky, Ëva Katona, et al.. (2015). Alloantibody developed in a factor XIII A subunit deficient patient during substitution therapy; characterization of the antibody. Haemophilia. 22(2). 268–275. 12 indexed citations
16.
Fan, Ying, Binghe Xu, Xiaoyan Ding, et al.. (2014). Icaritin efficacy and tolerability in advanced hepatocellular carcinoma: Final phase Ib result.. Journal of Clinical Oncology. 32(15_suppl). e15107–e15107. 4 indexed citations
17.
Chen, Min, Ali G. Turhan, Bo Zhang, et al.. (2014). Inhibitory Effects of Icaritin on TKI-Resistant CML Cells through Disruption of the BCR-ABL-GRB2-RAS-MAPK Signaling Pathway. Blood. 124(21). 1784–1784. 1 indexed citations
18.
Zhu, Jian, Zijian Li, Kun Meng, et al.. (2011). Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings. PLoS ONE. 6(8). e23720–e23720. 71 indexed citations
19.
Wang, Huijuan, et al.. (2011). Serum miR-574-5p. Shock. 37(3). 263–267. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by GI Murray Breakdown of academic impact, for papers by Lang Li Breakdown of academic impact, for papers by Shun-Fa Yang Breakdown of academic impact, for papers by Jinbo Yang Breakdown of academic impact, for papers by Kiyomi Yamauchi Breakdown of academic impact, for papers by Jianting Wen Breakdown of academic impact, for papers by Mi Ni Huang Breakdown of academic impact, for papers by Mingen Lin
Rankless by CCL
2026